Loading candles…
Indoco Remedies, incorporated in 1947 and headquartered in Mumbai, India, is a fully integrated pharmaceutical company operating in both domestic and international markets. The company engages in research and development, manufacturing of active pharmaceutical ingredients (APIs), finished dosage formulations (FDFs), and contract manufacturing. Its products include pharmaceutical formulations and APIs, serving 18 therapeutic segments. Indoco Remedies has a presence in India and exports to over 55 countries, functioning within the pharmaceutical industry.
| Type | Details | Date |
|---|---|---|
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 3 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 6 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 24 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 22 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.